Search

Your search keyword '"Tanavalee, Aree"' showing total 330 results
Start Over Author "Tanavalee, Aree"
330 results on '"Tanavalee, Aree"'

5. Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate.

Author

Suwan, Ammarin, Tanavalee, Chotetawan, Panyakhamlerd, Krasean, Ngarmukos, Srihatach, Chavaengkiat, Suchanant, Tanavalee, Aree, Amarase, Chavarin, and Bumphenkiatikul, Thanapob

Abstract

Background: Osteoporosis has been recognized as a significant health issue in Thailand. Pharmacological interventions are important way to prevent fracture. However, one of the main challenges in selecting a medication is high cost, particularly for brand-name drugs. Data on generic bisphosphonate use in Thai are still lacking. Therefore, our study aimed to assess the efficacy and safety of generic risedronate in postmenopausal Thai women with osteoporosis. Methods: This prospective study was conducted at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from December 2022 to January 2024. Serum C-terminal cross-linking telopeptide of type I collagen (CTX) and procollagen type I N-propeptide (P1NP) were measured at baseline. All participants subsequently received 35 milligrams of oral risedronate once weekly for 52 weeks. Serum CTX and P1NP were remeasured at different time points. BMD was reevaluated at 52 weeks after risedronate treatment initiation. Results: A total of 80 participants were included. The mean age was 65.2 ± 6.6 years. The mean body mass index (BMI) was 23.45 ± 3.49 kg/m2. The median (IQR) serum CTX level at 12 weeks was significantly lower than that at baseline (0.28 (0.16–0.46) ng/mL versus 0.44 (0.26–0.64) ng/mL, respectively; p value < 0.01). The suppression of serum CTX was confirmed at 52 weeks after treatment initiation. Compared with those at baseline, the serum P1NP levels were significantly lower at 24 weeks after treatment initiation (30.33 (19.19–39.58) ng/mL versus 41.90 (30.33–68.67) ng/mL, respectively; p value < 0.01). In terms of the BMD assessment at 52 weeks, significant improvements were observed in both areal BMD (g/cm2) and T scores at all measured sites compared with baseline. The lumbar spine, femoral neck, and total hip BMD increased from baseline by 4.76%, 3.84% and 4.54%, respectively. Conclusion: Postmenopausal women with osteoporosis who were treated with generic risedronate demonstrated significant suppression of the bone remodelling process at 3, 6, and 12 months after treatment initiation. Additionally, significant improvements in the lumbar spine, femoral neck, and total hip BMD were observed at 12 months of therapy. These findings suggest that generic risedronate could be considered a reasonable and interesting option for treating postmenopausal women with osteoporosis in Thailand. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Comparison of functional performance outcomes between oral patented crystalline glucosamine sulfate and platelet-rich plasma among knee osteoarthritis patients: a propensity score matching analysis.

Author

Amarase, Chavarin, Tanavalee, Aree, Ngarmukos, Srihatach, Tanavalee, Chotetawan, Jaruthien, Nonn, Somrak, Pakpoom, and Tantavisut, Saran

Abstract

Background: Among the medications used to treat knee osteoarthritis (OA), oral patented crystalline glucosamine sulfate (pCGS) and platelet-rich plasma (PRP) have become popular alternatives to painkillers or nonsteroidal anti-inflammatory drugs (NSAIDs). Although studies have shown that pCGS and PRP improve clinical outcomes, no study has compared outcomes between these optional treatments. We compared functional performance outcomes from baseline to the 1-year follow-up (FU) between oral pCGS and PRP in patients with knee OA. Materials and methods: Three hundred eighty-two patients receiving oral pCGS and 122 patients receiving PRP injections were enrolled for a review of functional performance outcomes, including a five-time sit-to-stand test (5xSST), time up-and-go test (TUGT), and 3-minute walk distance test (3MWDT). The patients were followed up for one year. The pCGS group received 1500 mg daily, whereas the PRP group received 2 cycles of intra-articular injections at week 0 and week 6. Using propensity score matching based on age, sex, height, weight, BMI, and Kellgren and Lawrence (KL) classification, all three functional performance outcomes were compared between the baseline (pretreatment), 6-week, 12-week, 24-week, and 1-year FUs. Results: With a ratio of 2:1 (pCGS: PRP), 204 patients in the pCGS group were matched with 102 patients in the PRP group. Compared with the baseline levels, the PRP group showed significant improvements in 5xSST and TUGT outcomes from 6 weeks and significant improvements in 3MWDT outcomes from 12 weeks, whereas the pCGS group showed significant improvements in TUGT outcomes from 6 weeks and significant improvements in 5xSST and 3MWDT outcomes from 12 weeks. At the 24-week and 1-year FU, both groups showed significant improvements in all three functional performance tests without adverse events. Conclusions: Although the PRP group showed faster improvements in 5xSST outcomes at six weeks, from the 12-week to 1-year FU, both the pCGS and PRP groups showed significant improvements in 5xSST, TUGT, and 3MWDT outcomes. As the use of PRP is more complicated and invasive than the use of oral pCGS, the benefits and drawbacks of selecting PRP over pCGS in knee OA treatment should be examined. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Reply to Letter to the Editor on “Comparison of Analgesic Efficacies of the iPACK (Interspace Between the Popliteal Artery and Capsule of the Posterior Knee) and Genicular Nerve Blocks Used in Combination With the Continuous Adductor Canal Block After Total Knee Arthroplasty: A Randomized Clinical Trial”

Author

Kampitak, Wirinaree, primary, Kertkiatkachorn, Wannida, additional, Ngarmukos, Srihatach, additional, Tanavalee, Aree, additional, Tanavalee, Chotetawan, additional, and Tangkittithaworn, Chonruethai, additional

Published
2024
Full Text
View/download PDF

11. Infrapatellar fat pad adipose tissue-derived macrophages display a predominant CD11c+CD206+ phenotype and express genotypes attributable to key features of OA pathogenesis

Author

Hengtrakool, Patchanika, primary, Leearamwat, Nitigorn, additional, Sengprasert, Panjana, additional, Wongphoom, Jutamas, additional, Chaichana, Thiamjit, additional, Taweevisit, Mana, additional, Ngarmukos, Srihatach, additional, Tanavalee, Aree, additional, Palaga, Tanapat, additional, and Reantragoon, Rangsima, additional

Published
2024
Full Text
View/download PDF

25. The Immunological Facets of Chondrocytes in Osteoarthritis: A Narrative Review

Author

Sengprasert, Panjana, Kamenkit, Ousakorn, Tanavalee, Aree, and Reantragoon, Rangsima

Abstract

Osteoarthritis (OA) is a disease in which the pathogenesis affects the joint and its surrounding tissues. Cartilage degeneration is the main hallmark of OA, and chondrocytes within the cartilage regulate matrix production and degradation. In patients with OA and in animal models of OA, the pathology of the disease relates to disequilibrium between anabolic and catabolic states of the cartilage. Moreover, chondrocyte phenotype and function are also immunologically altered. Under inflammatory conditions, chondrocytes increase production levels of inflammatory cytokines and cartilage-degrading enzymes, which further drive cartilage destruction. Chondrocytes also have an innate immune function and respond to damage-associated molecular patterns (DAMPs) and cartilage fragments by innate immune receptors. In addition, chondrocytes play a role in adaptive immune responses by acting as antigen-presenting cells and presenting cartilaginous antigens to T cells. Indirectly, chondrocytes are stimulated by pathogen-associated molecular patterns (PAMPs) present in the joints, a result of the microbiota of the host. Chondrocytes have both direct and indirect relationships with immune cells and the immune compartment of patients with OA. Therefore, chondrocytes serve as a target for immunotherapeutic approaches in OA. In this narrative review, we cover the aforementioned immune-related aspects of chondrocytes in OA.

Published
2024
Full Text
View/download PDF

32. Cytokine Profiling and Intra-Articular Injection of Autologous Platelet-Rich Plasma in Knee Osteoarthritis

Author

Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences, Riewruja, Kanyakorn, Phakham, Suphattra, Sompolpong, Patlapa, Reantragoon, Rangsima, Tanavalee, Aree, Ngarmukos, Srihatach, Udomsinprasert, Wanvisa, Suantawee, Tanyawan, Dechsupa, Sinsuda, Honsawek, Sittisak, Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences, Riewruja, Kanyakorn, Phakham, Suphattra, Sompolpong, Patlapa, Reantragoon, Rangsima, Tanavalee, Aree, Ngarmukos, Srihatach, Udomsinprasert, Wanvisa, Suantawee, Tanyawan, Dechsupa, Sinsuda, and Honsawek, Sittisak

Abstract

Osteoarthritis (OA) is a degenerative joint disease leading to joint pain and stiffness. Due to lack of effective treatments, physical and psychological disabilities caused by OA have a detrimental impact on the patient’s quality of life. Emerging evidence suggests that intra-articular injection of platelet-rich plasma (PRP) may provide favorable results since PRP comprises not only a high level of platelets but also a huge amount of cytokines, chemokines, and growth factors. However, the precise mechanism and standardization method remain uncertain. This study aimed to examine cytokine profiling in both PRP and platelet-poor plasma (PPP) of knee OA patients and to determine the effects of PRP on OA chondrocytes and knee OA patients. PRP contained a wide variety of cytokines, chemokines, growth factors, and autologous intra-articular PRP injection resulted in favorable outcomes in knee OA patients. Significant increases in levels of IL-1, IL-2, IL-7, IL-8, IL-9, IL-12, TNF-α, IL-17, PDGF-BB, bFGF, and MIP-1β were detected in PRP compared to PPP (p < 0.001). An in vitro study showed a marked increase in proliferation in OA chondrocytes cultured with PRP, compared to PPP and fetal bovine serum (p < 0.001). In a clinical study, knee OA patients treated with PRP showed improvement of physical function and pain, assessed by physical performance, Western Ontario and McMaster Universities Arthritis Index and visual analog scale. Our findings from both in vitro and clinical studies suggest that intra-articular PRP injection in knee OA patients may be a potential therapeutic strategy for alleviating knee pain and delaying the need for surgery.

Published
2022

44. Two or four injections of leukocyte-poor platelet-rich plasma for osteoarthritic knee did not affect changes of synovial cytokines and growth factors but similarly improved clinical outcomes

Author

Ngarmukos, Srihatach, primary, Tanavalee, Chotetawan, additional, Amarase, Chavarin, additional, Phakham, Suphattra, additional, Mingsiritham, Warayapa, additional, Reantragoon, Rangsima, additional, Leearamwat, Nitigorn, additional, Kongkaew, Thidarat, additional, Tharakhet, Kittipan, additional, Honsawek, Sittisak, additional, Dechsupa, Sinsuda, additional, and Tanavalee, Aree, additional

Published
2021
Full Text
View/download PDF

45. Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 1. Diagnosis and risk factors

Author

Ngarmukos, Srihatach, Kim, Kang Il, Wongsak, Siwadol, Chotanaphuti, Thanainit, Inaba, Yutaka, Chen, Cheng Fong, Liu, David, Unnanuntana, Aasis, Tan, Alvin, Pohl, Anthony, Angsugomutkul, Apisak, Patamarat, Apisit, Limtrakul, Arak, Tanavalee, Aree, Merican, Azhar, Abbas, Azlina, Badaruddin, Badrul Shah, Pongcharoen, Boonchana, Khanh, Bui Hong Thien, Li, Cao, Ngarmukos, Chaithavat, Sumettavanich, Charlee, Sumanasrethakul, Chavanont, Amarase, Chavarin, Chan, Chee Ken, Chang, Chong Bum, Tanavalee, Chotetawan, Mow, Christopher Scott, Leelasestaporn, Chumroonkiet, Yan, Chun Hoi, Tran, Dang Khoa, Campbell, David, Mustamsir, Edi, Arandia, Edsel Fernandez, Song, Eun Kyoo, Simanjuntak, G. Ruslan Nazaruddin, Muratsu, Hirotsugu, Choe, Hyonmin, Mohammad, Jamal Azmi, Fan, Jason Chi Ho, Bae, Ji Hoon, Kim, Ji Wan, San Juan, Jose Antonio, Syquia, Jose Fernando C., Kim, Jun Ho, Novito, Ki Ki, Sithitool, Kriskamol, Sakdinakiattikoon, Manoon, Matsubara, Masaaki, Lee, Mel S., Chilmi, Mohamad Zaim, Thaung, Myint, Lee, Myung Chul, Kongsakpaisal, Narathorn, Lo, Ngai Nung, Budhiparama, Nicolaas, Noree, Nikom, Sugano, Nobuhiko, Sa-ngasoongsong, Paphon, Taweekitikul, Pariwat, Bernardo, Peter, Rattanaprichavej, Piti, Pinsornsak, Piya, Wu, Po Kuei, Yuktanandana, Pongsak, Chaiyakit, Pruk, Jarayabhand, Rahat, Sorial, Rami Maher, Crawford, Ross W., Nagamine, Ryuji, Khuangsirikul, Saradej, Tantavisut, Saran, Thiengwittayaporn, Satit, Yeo, Seng Jin, Saengnipanthkul, Sukit, Suksumran, Supparurk, Meknavin, Surapoj, Chompoosang, Thakrit, Win, Than, Narinsorasak, Thana, Turajane, Thana, Reancharoen, Thanarat, Majima, Tokifumi, Chaweewannakorn, Ukrit, Kawinwonggowit, Viroj, Larbpaiboonpong, Viroj, Guo, Wanshou, Kosuwon, Weerachai, Chai, Wei, Maloney, William J., Teo, Yee Hong, Zhou, Yixin, Chen, Yunsu, Khanasuk, Yutthana, other, and, Ngarmukos, Srihatach, Kim, Kang Il, Wongsak, Siwadol, Chotanaphuti, Thanainit, Inaba, Yutaka, Chen, Cheng Fong, Liu, David, Unnanuntana, Aasis, Tan, Alvin, Pohl, Anthony, Angsugomutkul, Apisak, Patamarat, Apisit, Limtrakul, Arak, Tanavalee, Aree, Merican, Azhar, Abbas, Azlina, Badaruddin, Badrul Shah, Pongcharoen, Boonchana, Khanh, Bui Hong Thien, Li, Cao, Ngarmukos, Chaithavat, Sumettavanich, Charlee, Sumanasrethakul, Chavanont, Amarase, Chavarin, Chan, Chee Ken, Chang, Chong Bum, Tanavalee, Chotetawan, Mow, Christopher Scott, Leelasestaporn, Chumroonkiet, Yan, Chun Hoi, Tran, Dang Khoa, Campbell, David, Mustamsir, Edi, Arandia, Edsel Fernandez, Song, Eun Kyoo, Simanjuntak, G. Ruslan Nazaruddin, Muratsu, Hirotsugu, Choe, Hyonmin, Mohammad, Jamal Azmi, Fan, Jason Chi Ho, Bae, Ji Hoon, Kim, Ji Wan, San Juan, Jose Antonio, Syquia, Jose Fernando C., Kim, Jun Ho, Novito, Ki Ki, Sithitool, Kriskamol, Sakdinakiattikoon, Manoon, Matsubara, Masaaki, Lee, Mel S., Chilmi, Mohamad Zaim, Thaung, Myint, Lee, Myung Chul, Kongsakpaisal, Narathorn, Lo, Ngai Nung, Budhiparama, Nicolaas, Noree, Nikom, Sugano, Nobuhiko, Sa-ngasoongsong, Paphon, Taweekitikul, Pariwat, Bernardo, Peter, Rattanaprichavej, Piti, Pinsornsak, Piya, Wu, Po Kuei, Yuktanandana, Pongsak, Chaiyakit, Pruk, Jarayabhand, Rahat, Sorial, Rami Maher, Crawford, Ross W., Nagamine, Ryuji, Khuangsirikul, Saradej, Tantavisut, Saran, Thiengwittayaporn, Satit, Yeo, Seng Jin, Saengnipanthkul, Sukit, Suksumran, Supparurk, Meknavin, Surapoj, Chompoosang, Thakrit, Win, Than, Narinsorasak, Thana, Turajane, Thana, Reancharoen, Thanarat, Majima, Tokifumi, Chaweewannakorn, Ukrit, Kawinwonggowit, Viroj, Larbpaiboonpong, Viroj, Guo, Wanshou, Kosuwon, Weerachai, Chai, Wei, Maloney, William J., Teo, Yee Hong, Zhou, Yixin, Chen, Yunsu, Khanasuk, Yutthana, and other, and

Published
2021

46. Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis

Author

Amarase, Chavarin, Tanavalee, Aree, Larbpaiboonpong, Viroj, Lee, Myung Chul, Crawford, Ross W., Matsubara, Masaaki, Zhou, Yixin, Unnanuntana, Aasis, Tan, Alvin, Pohl, Anthony, Angsugomutkul, Apisak, Patamarat, Apisit, Limtrakul, Arak, Merican, Azhar, Abbas, Azlina, Badaruddin, Badrul Shah, Pongcharoen, Boonchana, Khanh, Bui Hong Thien, Li, Cao, Ngarmukos, Chaithavat, Sumettavanich, Charlee, Sumanasrethakul, Chavanont, Chan, Chee Ken, Chen, Cheng Fong, Chang, Chong Bum, Tanavalee, Chotetawan, Mow, Christopher Scott, Leelasestaporn, Chumroonkiet, Yan, Chun Hoi, Tran, Dang Khoa, Campbell, David, Liu, David, Mustamsir, Edi, Arandia, Edsel Fernandez, Song, Eun Kyoo, Simanjuntak, G. Ruslan Nazaruddin, Muratsu, Hirotsugu, Choe, Hyonmin, Mohammad, Jamal Azmi, Fan, Jason Chi Ho, Bae, Ji Hoon, Kim, Ji Wan, Juan, Jose Antonio San, Syquia, Jose Fernando C., Kim, Jun Ho, Kim, Kang Il, Novito, Ki Ki, Sithitool, Kriskamol, Sakdinakiattikoon, Manoon, Lee, Mel S., Chilmi, Mohamad Zaim, Thaung, Myint, Kongsakpaisal, Narathorn, Lo, Ngai Nung, Budhiparama, Nicolaas, Noree, Nikom, Sugano, Nobuhiko, Sa-ngasoongsong, Paphon, Taweekitikul, Pariwat, Bernardo, Peter, Rattanaprichavej, Piti, Pinsornsak, Piya, Wu, Po Kuei, Yuktanandana, Pongsak, Chaiyakit, Pruk, Jarayabhand, Rahat, Sorial, Rami Maher, Nagamine, Ryuji, Khuangsirikul, Saradej, Tantavisut, Saran, Thiengwittayaporn, Satit, Yeo, Seng Jin, Wongsak, Siwadol, Ngarmukos, Srihatach, Saengnipanthkul, Sukit, Suksumran, Supparurk, Meknavin, Surapoj, Chompoosang, Thakrit, Win, Than, Narinsorasak, Thana, Turajane, Thana, Chotanaphuti, Thanainit, Reancharoen, Thanarat, Majima, Tokifumi, Chaweewannakorn, Ukrit, Kawinwonggowit, Viroj, Guo, Wanshou, Kosuwon, Weerachai, Chai, Wei, Maloney, William J., Teo, Yee Hong, Chen, Yunsu, Inaba, Yutaka, Khanasuk, Yutthana, other, and, Amarase, Chavarin, Tanavalee, Aree, Larbpaiboonpong, Viroj, Lee, Myung Chul, Crawford, Ross W., Matsubara, Masaaki, Zhou, Yixin, Unnanuntana, Aasis, Tan, Alvin, Pohl, Anthony, Angsugomutkul, Apisak, Patamarat, Apisit, Limtrakul, Arak, Merican, Azhar, Abbas, Azlina, Badaruddin, Badrul Shah, Pongcharoen, Boonchana, Khanh, Bui Hong Thien, Li, Cao, Ngarmukos, Chaithavat, Sumettavanich, Charlee, Sumanasrethakul, Chavanont, Chan, Chee Ken, Chen, Cheng Fong, Chang, Chong Bum, Tanavalee, Chotetawan, Mow, Christopher Scott, Leelasestaporn, Chumroonkiet, Yan, Chun Hoi, Tran, Dang Khoa, Campbell, David, Liu, David, Mustamsir, Edi, Arandia, Edsel Fernandez, Song, Eun Kyoo, Simanjuntak, G. Ruslan Nazaruddin, Muratsu, Hirotsugu, Choe, Hyonmin, Mohammad, Jamal Azmi, Fan, Jason Chi Ho, Bae, Ji Hoon, Kim, Ji Wan, Juan, Jose Antonio San, Syquia, Jose Fernando C., Kim, Jun Ho, Kim, Kang Il, Novito, Ki Ki, Sithitool, Kriskamol, Sakdinakiattikoon, Manoon, Lee, Mel S., Chilmi, Mohamad Zaim, Thaung, Myint, Kongsakpaisal, Narathorn, Lo, Ngai Nung, Budhiparama, Nicolaas, Noree, Nikom, Sugano, Nobuhiko, Sa-ngasoongsong, Paphon, Taweekitikul, Pariwat, Bernardo, Peter, Rattanaprichavej, Piti, Pinsornsak, Piya, Wu, Po Kuei, Yuktanandana, Pongsak, Chaiyakit, Pruk, Jarayabhand, Rahat, Sorial, Rami Maher, Nagamine, Ryuji, Khuangsirikul, Saradej, Tantavisut, Saran, Thiengwittayaporn, Satit, Yeo, Seng Jin, Wongsak, Siwadol, Ngarmukos, Srihatach, Saengnipanthkul, Sukit, Suksumran, Supparurk, Meknavin, Surapoj, Chompoosang, Thakrit, Win, Than, Narinsorasak, Thana, Turajane, Thana, Chotanaphuti, Thanainit, Reancharoen, Thanarat, Majima, Tokifumi, Chaweewannakorn, Ukrit, Kawinwonggowit, Viroj, Guo, Wanshou, Kosuwon, Weerachai, Chai, Wei, Maloney, William J., Teo, Yee Hong, Chen, Yunsu, Inaba, Yutaka, Khanasuk, Yutthana, and other, and

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results